Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Hoffman

Showing results (921-930 of 1,048) with videos related to

Pageof 105
Sort By:
Medicine and Science in Sports and Exercise|June 29, 2007
Subcutaneous fat alterations resulting from an upper-body resistance training programMatthew A Kostek, Linda S Pescatello, Richard L Seip, et al.
JAMA Neurology|May 27, 2020
Safety, Tolerability, and Efficacy of Viltolarsen in Boys With Duchenne Muscular Dystrophy Amenable to Exon 53 Skipping: A Phase 2 Randomized Clinical TrialPaula R Clemens, Vamshi K Rao, Anne M Connolly, et al.
Applied Physiology, Nutrition, and Metabolism = Physiologie Appliquee, Nutrition Et Metabolisme|October 17, 2017
Expression of macrophage genes within skeletal muscle correlates inversely with adiposity and insulin resistance in humansDongmei Liu, Flor Elisa Morales, Heidi B IglayReger, et al.
Plos One|April 16, 2016
Discovery of Metabolic Biomarkers for Duchenne Muscular Dystrophy within a Natural History StudySimina M Boca, Maki Nishida, Michael Harris, et al.
Nature Communications|October 18, 2017
Myoblasts and macrophages are required for therapeutic morpholino antisense oligonucleotide delivery to dystrophic muscleJames S Novak, Marshall W Hogarth, Jessica F Boehler, et al.
Journal of Neuromuscular Diseases|January 8, 2019
Report of a TREAT-NMD/World Duchenne Organisation Meeting on Dystrophin Quantification MethodologyAnnemieke Aartsma-Rus, Jennifer Morgan, Pallavi Lonkar, et al.
Nature Communications|March 25, 2018
Author Correction: Myoblasts and macrophages are required for therapeutic morpholino antisense oligonucleotide delivery to dystrophic muscleJames S Novak, Marshall W Hogarth, Jessica F Boehler, et al.
Human Molecular Genetics|November 1, 1996
Mutations that disrupt the carboxyl-terminus of gamma-sarcoglycan cause muscular dystrophyE M McNally, D Duggan, J R Gorospe, et al.
Oncotarget|April 14, 2017
Association between tumor architecture derived from generalized Q-space MRI and survival in glioblastomaErik N Taylor, Yao Ding, Shan Zhu, et al.
Nature Communications|January 17, 2018
Author Correction: Myoblasts and macrophages are required for therapeutic morpholino antisense oligonucleotide delivery to dystrophic muscleJames S Novak, Marshall W Hogarth, Jessica F Boehler, et al.
Pageof 105

Showing results (921-930 of 1,048) with videos related to

Sort By:
Pageof 105
Medicine and Science in Sports and Exercise|June 29, 2007
Subcutaneous fat alterations resulting from an upper-body resistance training programMatthew A Kostek, Linda S Pescatello, Richard L Seip, et al.
JAMA Neurology|May 27, 2020
Safety, Tolerability, and Efficacy of Viltolarsen in Boys With Duchenne Muscular Dystrophy Amenable to Exon 53 Skipping: A Phase 2 Randomized Clinical TrialPaula R Clemens, Vamshi K Rao, Anne M Connolly, et al.
Applied Physiology, Nutrition, and Metabolism = Physiologie Appliquee, Nutrition Et Metabolisme|October 17, 2017
Expression of macrophage genes within skeletal muscle correlates inversely with adiposity and insulin resistance in humansDongmei Liu, Flor Elisa Morales, Heidi B IglayReger, et al.
Plos One|April 16, 2016
Discovery of Metabolic Biomarkers for Duchenne Muscular Dystrophy within a Natural History StudySimina M Boca, Maki Nishida, Michael Harris, et al.
Nature Communications|October 18, 2017
Myoblasts and macrophages are required for therapeutic morpholino antisense oligonucleotide delivery to dystrophic muscleJames S Novak, Marshall W Hogarth, Jessica F Boehler, et al.
Journal of Neuromuscular Diseases|January 8, 2019
Report of a TREAT-NMD/World Duchenne Organisation Meeting on Dystrophin Quantification MethodologyAnnemieke Aartsma-Rus, Jennifer Morgan, Pallavi Lonkar, et al.
Nature Communications|March 25, 2018
Author Correction: Myoblasts and macrophages are required for therapeutic morpholino antisense oligonucleotide delivery to dystrophic muscleJames S Novak, Marshall W Hogarth, Jessica F Boehler, et al.
Human Molecular Genetics|November 1, 1996
Mutations that disrupt the carboxyl-terminus of gamma-sarcoglycan cause muscular dystrophyE M McNally, D Duggan, J R Gorospe, et al.
Oncotarget|April 14, 2017
Association between tumor architecture derived from generalized Q-space MRI and survival in glioblastomaErik N Taylor, Yao Ding, Shan Zhu, et al.
Nature Communications|January 17, 2018
Author Correction: Myoblasts and macrophages are required for therapeutic morpholino antisense oligonucleotide delivery to dystrophic muscleJames S Novak, Marshall W Hogarth, Jessica F Boehler, et al.
Pageof 105